Skip to main content
NCBI home page
Gut logoLink to Gut
. 1985 Jan;26(1):75–80. doi: 10.1136/gut.26.1.75

Nufenoxole, a new antidiarrhoeal agent, inhibits fluid secretion in the human jejunum.

K J Moriarty, D D Rolston, M J Kelly, M Shield, M L Clark
PMCID: PMC1432389  PMID: 2578119

Abstract

Nufenoxole is an orally active antidiarrhoeal agent which binds to opioid receptors in the brain and myenteric plexus of the intestine. A perfusion technique has been used to investigate the effect of nufenoxole (1 mg/kg intrajejunally) on water and solute transport stimulated by the secretagogue, dioctyl sodium sulphosuccinate, in the human jejunum in vivo. Nufenoxole reversed the direction of jejunal transport of salt and water from net secretion to net absorption. These changes in water and electrolyte transport were inhibited by intravenous naloxone, the opioid antagonist. Nufenoxole possesses potent antisecretory properties, which are mediated via opioid receptors and may contribute to its antidiarrhoeal action in man.

Full text

PDF
75

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beubler E., Juan H. Effect of ricinoleic acid and other laxatives on net water flux and prostaglandin E release by the rat colon. J Pharm Pharmacol. 1979 Oct;31(10):681–685. doi: 10.1111/j.2042-7158.1979.tb13628.x. [DOI] [PubMed] [Google Scholar]
  2. Beubler E., Lembeck F. Inhibition of stimulated fluid secretion in the rat small and large intestine by opiate agonists. Naunyn Schmiedebergs Arch Pharmacol. 1979 Mar;306(2):113–118. doi: 10.1007/BF00498980. [DOI] [PubMed] [Google Scholar]
  3. Chavkin C., Goldstein A. Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature. 1981 Jun 18;291(5816):591–593. doi: 10.1038/291591a0. [DOI] [PubMed] [Google Scholar]
  4. Chavkin C., James I. F., Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science. 1982 Jan 22;215(4531):413–415. doi: 10.1126/science.6120570. [DOI] [PubMed] [Google Scholar]
  5. Coupar I. M. Inhibition by morphine of prostaglandin-stimulated fluid secretion in rat jejunum. Br J Pharmacol. 1978 May;63(1):57–63. doi: 10.1111/j.1476-5381.1978.tb07774.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DANIEL E. E., SUTHERLAND W. H., BOGOCH A. Effects of morphine and other drugs on motility of the terminal ileum. Gastroenterology. 1959 Apr;36(4):510–523. [PubMed] [Google Scholar]
  7. Dajani E. Z., Bianchi R. G., East P. F., Bloss J. L., Adelstein G. W., Yen C. H. The pharmacology of SC-27166: a novel antidiarrheal agent. J Pharmacol Exp Ther. 1977 Dec;203(3):512–526. [PubMed] [Google Scholar]
  8. Dobbins J., Racusen L., Binder H. J. Effect of D-alanine methionine enkephalin amide on ion transport in rabbit ileum. J Clin Invest. 1980 Jul;66(1):19–28. doi: 10.1172/JCI109830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Donowitz M., Binder H. J. Effect of dioctyl sodium sulfosuccinate on colonic fluid and electrolyte movement. Gastroenterology. 1975 Oct;69(4):941–950. [PubMed] [Google Scholar]
  10. Farack U. M., Kautz U., Loeschke K. Loperamide reduces the intestinal secretion but not the mucosal cAMP accumulation induced by choleratoxin. Naunyn Schmiedebergs Arch Pharmacol. 1981 Sep;317(2):178–179. doi: 10.1007/BF00500077. [DOI] [PubMed] [Google Scholar]
  11. Fishman J., Roffwarg H., Hellman L. Disposition of naloxone-7,8,3H in normal and narcotic-dependent men. J Pharmacol Exp Ther. 1973 Dec;187(3):575–580. [PubMed] [Google Scholar]
  12. Grossman A., Moult P. J., McIntyre H., Evans J., Silverstone T., Rees L. H., Besser G. M. Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight-loss related amenorrhoea. Clin Endocrinol (Oxf) 1982 Oct;17(4):379–388. doi: 10.1111/j.1365-2265.1982.tb01603.x. [DOI] [PubMed] [Google Scholar]
  13. Hardcastle J., Hardcastle P. T., Read N. W., Redfern J. S. The action of loperamide in inhibiting prostaglandin-induced intestinal secretion in the rat. Br J Pharmacol. 1981 Nov;74(3):563–569. doi: 10.1111/j.1476-5381.1981.tb10465.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hughes S., Higgs N. B., Turnberg L. A. Antidiarrhoeal activity of loperamide: studies of its influence on ion transport across rabbit ileal mucosa in vitro. Gut. 1982 Nov;23(11):974–979. doi: 10.1136/gut.23.11.974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kachur J. F., Miller R. J., Field M. Control of guinea pig intestinal electrolyte secretion by a delta-opiate receptor. Proc Natl Acad Sci U S A. 1980 May;77(5):2753–2756. doi: 10.1073/pnas.77.5.2753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Karim S. M., Adaikan P. G. The effect of loperamide on prostaglandin induced diarrhoea in rat and man. Prostaglandins. 1977 Feb;13(2):321–331. doi: 10.1016/0090-6980(77)90011-9. [DOI] [PubMed] [Google Scholar]
  17. Korey A., Zilm D. H., Sellers E. M. Dependence liability of two antidiarrheals, nufenoxole and loperamide. Clin Pharmacol Ther. 1980 May;27(5):659–664. doi: 10.1038/clpt.1980.93. [DOI] [PubMed] [Google Scholar]
  18. Kosterlitz H. W., Lord J. A., Paterson S. J., Waterfield A. A. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors. Br J Pharmacol. 1980 Feb;68(2):333–342. doi: 10.1111/j.1476-5381.1980.tb10422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lembeck F., Beubler E. Inhibition of PGE1 induced intestinal secretion by the synthetic enkephalin analogue FK 33-824. Naunyn Schmiedebergs Arch Pharmacol. 1979 Sep;308(3):261–264. doi: 10.1007/BF00501391. [DOI] [PubMed] [Google Scholar]
  20. Lloyd J. B., Whelan W. J. An improved method for enzymic determination of glucose in the presence of maltose. Anal Biochem. 1969 Sep;30(3):467–470. doi: 10.1016/0003-2697(69)90143-2. [DOI] [PubMed] [Google Scholar]
  21. Mackerer C. R., Brougham L. R., East P. F., Bloss J. L., Dajani E. Z., Clay G. A. Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther. 1977 Dec;203(3):527–538. [PubMed] [Google Scholar]
  22. McKay J. S., Linaker B. D., Higgs N. B., Turnberg L. A. Studies of the antisecretory activity of morphine in rabbit ileum in vitro. Gastroenterology. 1982 Feb;82(2):243–247. [PubMed] [Google Scholar]
  23. McKay J. S., Linaker B. D., Turnberg L. A. Influence of opiates on ion transport across rabbit ileal mucosa. Gastroenterology. 1981 Feb;80(2):279–284. [PubMed] [Google Scholar]
  24. Paterson S. J., Robson L. E., Kosterlitz H. W. Classification of opioid receptors. Br Med Bull. 1983 Jan;39(1):31–36. doi: 10.1093/oxfordjournals.bmb.a071787. [DOI] [PubMed] [Google Scholar]
  25. Pert C. B., Snyder S. H. Opiate receptor: demonstration in nervous tissue. Science. 1973 Mar 9;179(4077):1011–1014. doi: 10.1126/science.179.4077.1011. [DOI] [PubMed] [Google Scholar]
  26. Piercey M. F., Ruwart M. J. Naloxone inhibits the anti-diarrhoeal activity of loperamide. Br J Pharmacol. 1979 Jul;66(3):373–375. doi: 10.1111/j.1476-5381.1979.tb10840.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Powell D. W. Muscle or mucosa: the site of action of antidiarrheal opiates? Gastroenterology. 1981 Feb;80(2):406–408. [PubMed] [Google Scholar]
  28. Sandhu B. K., Tripp J. H., Candy D. C., Harries J. T. Loperamide: studies on its mechanism of action. Gut. 1981 Aug;22(8):658–662. doi: 10.1136/gut.22.8.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Saunders D. R., Sillery J., Rachmilewitz D. Effect of dioctyl sodium sulfosuccinate on structure and function of rodent and human intestine. Gastroenterology. 1975 Aug;69(2):380–386. [PubMed] [Google Scholar]
  30. Schiller L. R., Davis G. R., Santa Ana C. A., Morawski S. G., Fordtran J. S. Studies of the mechanism of the antidiarrheal effect of codeine. J Clin Invest. 1982 Nov;70(5):999–1008. doi: 10.1172/JCI110711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Simon E. J. In search of the opiate receptor. Am J Med Sci. 1973 Sep;266(3):160–168. doi: 10.1097/00000441-197309000-00001. [DOI] [PubMed] [Google Scholar]
  32. Sladen G. E., Dawson A. M. An evaluation of perfusion techniques in the study of water and electrolyte absorption in man: the problem of endogenous secretions. Gut. 1968 Oct;9(5):530–535. doi: 10.1136/gut.9.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sladen G. E., Dawson A. M. Further studies on the perfusion method for measuring intestinal absorption in man: the effects of a proximal occlusive balloon and a mixing segment. Gut. 1970 Nov;11(11):947–954. doi: 10.1136/gut.11.11.947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. VAUGHAN WILLIAMS E. M. The mode of action of drugs upon intestinal motility. Pharmacol Rev. 1954 Jun;6(2):159–190. [PubMed] [Google Scholar]
  35. Wingate D. L., Sandberg R. J., Phillips S. F. A comparison of stable and 14 C-labelled polyethylene glycol as volume indicators in the human jejunum. Gut. 1972 Oct;13(10):812–815. doi: 10.1136/gut.13.10.812. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES